Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

Delfi Diagnostics announces key data, study design for its liquid biopsy test

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing

June 3, 2024

Expert warns of the continuous dangers posed by polio and other enteroviruses

Consistently high vaccination rates and global health surveillance programs have helped eliminate poliomyelitis (polio) in almost all countries of the world, except Afghanistan and Pakistan.

April 29, 2024

New CDC report highlights disparities in flu hospitalization and vaccination

Black, Hispanic, and American Indian/Alaska Native (AI/AN) adults in the United States are more likely to be hospitalized with flu, as well as less likely

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.